Sapna S. Shah;Hon-Chung Tsui;Cheng Wang;Michelle Laci Wrobleski;Anandan Palani;Ashwin U. Rao;Xianhai Huang;Dong Xiao;Sunil Paliwal;Neng-Yang Shih
发明人:
Anandan Palani,Xianhai Huang,Dong Xiao,Sapna S. Shah,Sunil Paliwal,Hon-Chung Tsui,Michelle Laci Wrobleski,Ashwin U. Rao,Cheng Wang,Neng-Yang Shih
申请号：
US13245403
公开号：
US20120295879A1
申请日:
2011.09.26
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A compound having the general structure shown in Formula I:or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
